Wyeth Renews and Expands License Agreement with Ingenuity Systems
News May 02, 2007
Wyeth's research and development teams will utilize IPA in multiple research areas, including its pharmacogenomics group that focuses on approaches to identifying biomarkers.
"We are pleased that Wyeth has selected Ingenuity Systems as a key partner for its research programs," said Peter DiLaura, Senior Vice President of Commercial Operations at Ingenuity.
"Wyeth has been a valued customer since 2003, and we view this renewal as a testament to our ability to provide relevant and valuable solutions for researchers who need to analyze and understand the biological and chemical relationships within their experimental systems," DiLaura continued.
IPA is a software and content solution that provides insights and understanding of complex biological and chemical systems at the core of life science research.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019